Announce Date | 05/20/2025 |
EPS Normalized Actual | $3.5 (Beat by $0.64) |
EPS GAAP Actual | $3.5 (Beat by $0.64) |
Revenue Actual | $2.73908B |
Revenue Surprise | Beat by $2739.08M |
Announce Date | 07/30/2025 (Pre-Market) |
EPS Normalized Estimate | $3.48616 |
EPS GAAP Estimate | $3.48616 |
Revenue Estimate | $2.665761643B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Oct 2028 | 23.7 | 5.63 | 22.50256 | 25.51249 | 3 |
Oct 2027 | 21.04 | 6.34 | 19.97696 | 22.64906 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Apr 2025) | 3.53 | 0.13536 | 2.73908B | -3.59% | 105.46M |
FQ1 2025 (Jan 2025) | 1.76 | 1.76 | 0.459296B | -324.09% | 459.3M |
FQ4 2024 (Oct 2024) | 4.67 | 4.67 | 3.33346B | 9.4% | 3333.46M |
FQ3 2024 (Jul 2024) | 3.64 | 3.64 | 4.70858B | 42.92% | 4708.58M |
FQ2 2024 (Apr 2024) | 4.6 | 4.6 | 2.83749B | 100% | 2837.49M |
FQ1 2024 (Jan 2024) | 2.25 | 2.25 | 1.94785B | 8.61% | 1947.85M |
FQ4 2023 (Oct 2023) | 4.15 | 4.15 | 3.02015B | 100% | 3020.15M |
FQ3 2023 (Jul 2023) | 3.77 | 3.77 | 2.68764B | 100% | 2687.64M |
FQ4 Announce Date
07/30/2025 (Pre-Market)
Consensus EPS Estimates
3.48616
Consensus Revenue Estimates
2.665761643B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 5.55664 | -- | 5.39007 | 5.8387 | 5 |
FQ3 2027 (Jul 2027) | 4.35763 | -- | 4.22701 | 4.57882 | 11 |
FQ2 2027 (Apr 2027) | 3.65905 | -- | 3.54937 | 3.84478 | 10 |
FQ1 2027 (Jan 2027) | 2.17886 | -- | 2.13302 | 2.23905 | 9 |
FQ4 2026 (Oct 2026) | 4.53364 | -- | 4.12234 | 5.14241 | 5 |
FQ3 2026 (Jul 2026) | 3.25981 | -- | 2.96408 | 3.69753 | 5 |
FQ2 2026 (Apr 2026) | 2.56541 | -37.6 | 2.33267 | 2.90989 | 5 |
FQ1 2026 (Jan 2026) | 1.97673 | 10.96 | 1.87518 | 2.06969 | 9 |
FQ4 2025 (Oct 2025) | 4.29587 | -8.71 | 3.90614 | 4.87271 | 10 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 3.62B | -- | 3.53B | 3.76B | 10 |
FQ3 2027 (Jul 2027) | 3.02B | -- | 2.95B | 3.14B | 7 |
FQ2 2027 (Apr 2027) | 2.72B | -- | 2.66B | 2.83B | 5 |
FQ1 2027 (Jan 2027) | 1.99B | -- | 1.95B | 2.03B | 5 |
FQ4 2026 (Oct 2026) | 3.12B | -- | 2.91B | 3.45B | 5 |
FQ3 2026 (Jul 2026) | 2.43B | -- | 2.26B | 2.69B | 5 |
FQ2 2026 (Apr 2026) | 2.13B | -28.85 | 1.98B | 2.35B | 5 |
FQ1 2026 (Jan 2026) | 1.86B | 75.34 | 1.79B | 1.93B | 4 |
FQ4 2025 (Oct 2025) | 3.21B | -3.89 | 2.98B | 3.54B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Apr 2025) | 3.39464 | 3.53 | 0.13536 | 3.83% |
FQ1 2025 (Jan 2025) | 1.76 | 1.76 | 100% | |
FQ4 2024 (Oct 2024) | 4.67 | 4.67 | 100% | |
FQ3 2024 (Jul 2024) | 3.64 | 3.64 | 100% | |
FQ2 2024 (Apr 2024) | 4.6 | 4.6 | 100% | |
FQ1 2024 (Jan 2024) | 2.25 | 2.25 | 100% | |
FQ4 2023 (Oct 2023) | 4.15 | 4.15 | 100% | |
FQ3 2023 (Jul 2023) | 3.77 | 3.77 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Apr 2025) | $2.63B | $2.74B | $105.46M | 3.85% |
FQ1 2025 (Jan 2025) | $0B | $0.46B | $459.3M | 100% |
FQ4 2024 (Oct 2024) | $0B | $3.33B | $3333.46M | 100% |
FQ3 2024 (Jul 2024) | $0B | $4.71B | $4708.58M | 100% |
FQ2 2024 (Apr 2024) | $0B | $2.84B | $2837.49M | 100% |
FQ1 2024 (Jan 2024) | $0B | $1.95B | $1947.85M | 100% |
FQ4 2023 (Oct 2023) | $0B | $3.02B | $3020.15M | 100% |
FQ3 2023 (Jul 2023) | $0B | $2.69B | $2687.64M | 100% |